Part of the Medicine and Health Sciences Commons

Works by Natalie A. Jabbour-Leung in Medicine and Health Sciences

2015

SYNTHETIC LETHALITY OF CDK INHIBITION AND DOXORUBICIN IN TRIPLE-NEGATIVE BREAST CANCER REQUIRES P53 INACTIVATION, Natalie A. Jabbour-Leung
Dissertations and Theses (Open Access)

PDF